abstract |
Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 nare disclosed in accordance with the invention. The invention further relates to vectors, ncompositions, and methods of treatment and/or detection using the FLT3 antigen binding nmolecules and engineered immune cells. |